5 Value Stocks To Watch In The Healthcare Sector
Portfolio Pulse from Benzinga Insights
Benzinga Insights has identified five value stocks in the healthcare sector based on low P/E multiples, indicating potential undervaluation. The stocks include Cross Country Healthcare (CCRN), Akerna (KERN), Viatris (VTRS), Quoin Pharmaceuticals (QNRX), and Adial Pharmaceuticals (ADIL). CCRN reported a decrease in Q3 EPS, KERN reported a negative EPS that worsened from Q1, VTRS reported an increase in EPS and a decrease in dividend yield, QNRX showed an improvement in its negative EPS, and ADIL also improved its negative EPS.
November 13, 2023 | 2:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adial Pharmaceuticals improved its negative EPS from Q1 to Q2, which may be interpreted as a positive trend by the market.
An improvement in negative EPS could suggest that the company is moving towards profitability, potentially leading to a positive short-term impact on the stock price.
CONFIDENCE 65
IMPORTANCE 50
RELEVANCE 60
POSITIVE IMPACT
Quoin Pharmaceuticals showed improvement in its negative EPS from Q2 to Q3, which could be seen as a positive development by investors.
Improvement in negative EPS may be viewed as a step in the right direction, potentially leading to a positive short-term impact on the stock price.
CONFIDENCE 65
IMPORTANCE 50
RELEVANCE 60
NEUTRAL IMPACT
Viatris reported an increase in EPS but a decrease in dividend yield, which could have a mixed impact on investor perception.
While the increase in EPS is positive, the decrease in dividend yield might offset some of the potential positive impact on the stock price.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 75
NEGATIVE IMPACT
Cross Country Healthcare reported a 43.48% decrease in Q3 EPS compared to Q2, which may concern investors about the company's short-term profitability.
A significant decrease in EPS typically concerns investors and could lead to a negative short-term impact on the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Akerna's EPS worsened from Q1 to Q3, indicating potential ongoing financial challenges that could negatively affect investor sentiment.
Worsening negative EPS is a bearish signal that can lead to a decline in stock price as it reflects financial difficulties.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70